Personalized systems Cancer Biology

Personalized systems Cancer Biology



The Gronemeyer team addresses questions of cancer systems biology


Current projects

  1. Identification of perturbed gene-regulatory networks in primary prostate cancer
  2. Cell fate trajectories during pluripotency induction and tumorigenesis in isogenic systems
  3. Characterization of the epigenetic enzyme TET: an integrative approach

Collaborations and networks

Multiple collaborations in France and abroad

Funding and partners

  • ANR
  • INCa


Awards and recognitions

  • 2015  Prix René et Andrée Duquesne (Ligue contre le Cancer)
  • 2014  Thomson Reuters declares H Gronemeyer as one of the 3,200 most influential scientific minds world-wide
  • since 2019 Contributing member of the F1000 Faculty
  • since 2017 Adviser of the High Council for the Evaluation of Research and Higher Education (HCERES)
  • since 2016 Member of the European Academy of Cancer Sciences (EACS)
  • since 1995 Member of the European Molecular Biology Organization (EMBO)
  • Present member and/or Chair of Scientific evaluation committees : European Research Council (ERC), Fundação para a Ciência e a Tecnologia (FCT), European Science Foundation (ESF), ARC Foundation